» Articles » PMID: 38342960

The Role of Confined Placental Mosaicism in Fetal Growth Restriction: A Retrospective Cohort Study

Overview
Journal Prenat Diagn
Publisher Wiley
Date 2024 Feb 11
PMID 38342960
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate which cytogenetic characteristics of confined placental mosaicism (CPM) detected in the first trimester chorionic villi and/or placentas in terms of chromosome aberration, cell lineage involved and trisomy origin will lead to fetal growth restriction and low birthweight.

Methods: Cohort study using routinely collected perinatal data and cytogenetic data of non-invasive prenatal testing, the first trimester chorionic villi sampling and postnatal placentas.

Results: 215 CPM cases were found. Fetal growth restriction (FGR) and low birthweight below the 10 percentile (BW < p10) were seen in 34.0% and 23.1%, respectively. Excluding cases of trisomy 16, 29.1% showed FGR and 17.9% had a BW < p10. The highest rate of FGR and BW < p10 was found in CPM type 3, but differences with type 1 and 2 were not significant. FGR and BW < p10 were significantly more often observed in cases with meiotic trisomies.

Conclusion: There is an association between CPM and FGR and BW < p10. This association is not restricted to trisomy 16, neither to CPM type 3, nor to CPM involving a meiotic trisomy. Pregnancies with all CPM types and origins should be considered to be at increased risk of FGR and low BW < p10. A close prenatal fetal monitoring is indicated in all cases of CPM.

Citing Articles

Trophectoderm Biopsy: Present State of the Art.

De Vos A, De Munck N Genes (Basel). 2025; 16(2).

PMID: 40004463 PMC: 11854799. DOI: 10.3390/genes16020134.


Re-reply to Sabbagh et al.

Van Opstal D, Faas B Eur J Hum Genet. 2025; .

PMID: 39979678 DOI: 10.1038/s41431-025-01806-z.


The Impact of Chromosomal Mosaicisms on Prenatal Diagnosis and Genetic Counseling-A Narrative Review.

Militaru M, Babliuc I, Bloaje-Florica V, Danci V, Filip-Deac I, Kutasi E J Pers Med. 2024; 14(7).

PMID: 39064028 PMC: 11277968. DOI: 10.3390/jpm14070774.


Clinical outcomes of screen-positive genome-wide cfDNA cases for trisomy 20: results from the global expanded NIPT Consortium.

Soster E, Mossfield T, Menezes M, Agenbag G, Dubois M, Gekas J Mol Cytogenet. 2024; 17(1):9.

PMID: 38627791 PMC: 11021009. DOI: 10.1186/s13039-024-00677-1.